Refine
Has Fulltext
- yes (16)
Is part of the Bibliography
- yes (16)
Document Type
- Journal article (16)
Language
- English (16)
Keywords
- glioblastoma (4)
- astrocytoma (3)
- glioblastoma multiforme (3)
- recurrence (3)
- therapy (3)
- CNS disorders (2)
- MPS1 (2)
- low-grade glioma (2)
- mRNA (2)
- protein (2)
- relapse (2)
- temozolomide (2)
- 3D ex vivo models (1)
- 3D in vitro model (1)
- Bevacizumab (1)
- Bone chips (1)
- CXCR4 (1)
- Fibrin glue (1)
- Glioblastoma (1)
- IDH (1)
- Irradiation (1)
- Lateral suboccipital craniectomy (1)
- MGMT (1)
- MGMT promoter methylation (1)
- Osteogeneration (1)
- PET/CT (1)
- Pentixafor (1)
- Spinal dissemination (1)
- TTFields (1)
- TTK (1)
- Temozolomide (1)
- Tumor Treating Fields (TTFields) (1)
- Tumor-Treating Fields (TTFields) (1)
- \(^{68}\)Ga-Pentixafor (1)
- amyloidoma (1)
- behavior (1)
- blood-brain barrier (1)
- blood–brain barrier (1)
- brain (1)
- brain tumor (1)
- cancer stem cells (1)
- cervical spine (1)
- chemokine receptor-4 (1)
- craniovertebral junction (1)
- expression (1)
- glioblastoma multiforme (GBM) (1)
- glioma (1)
- human brain microvascular endothelial cells (HBMVEC) (1)
- human cells (1)
- imaging (1)
- liponeurocytoma (1)
- liquid biopsy (1)
- mRNA expression (1)
- medulloblastoma (1)
- meningioma (1)
- metastasis (1)
- metastasis-associated in colon cancer 1 (MACC1) (1)
- minimally invasive (1)
- molecular imaging (1)
- molecular signature (1)
- multifocal growth (1)
- neurocytoma (1)
- neurodegenerative disease (1)
- neurooncology (1)
- neurovascular unit (1)
- organoids (1)
- organotypic hippocampal slice cultures (OHSC) (1)
- positron emission tomography/computed tomography (1)
- prognostic marker (1)
- resistance (1)
- spinal tumor operation (1)
- suppressor (1)
- therapy response (1)
- tumor slice cultures (1)
- vestibular schwannoma (1)
We have recently demonstrated CXCR4 overexpression in vestibular schwannomas (VS). This study investigated the feasibility of CXCR4-directed positron emission tomography/computed tomography (PET/CT) imaging of VS using the radiolabeled chemokine ligand [\(^{68}\)Ga]Pentixafor.
Methods: 4 patients with 6 primarily diagnosed or pre-treated/observed VS were enrolled. All subjects underwent [\(^{68}\)Ga]Pentixafor PET/CT prior to surgical resection. Images were analyzed visually and semi-quantitatively for CXCR4 expression including calculation of tumor-to-background ratios (TBR). Immunohistochemistry served as standard of reference in three patients.
Results: [\(^{68}\)Ga]Pentixafor PET/CT was visually positive in all cases. SUV\(_{mean}\) and SUV\(_{max}\) were 3.0 ± 0.3 and 3.8 ± 0.4 and TBR\(_{mean}\) and TBR\(_{max}\) were 4.0 ± 1.4 and 5.0 ± 1.7, respectively. Histological analysis confirmed CXCR4 expression in tumors.
Conclusion: Non-invasive imaging of CXCR4 expression using [\(^{68}\)Ga]Pentixafor PET/CT of VS is feasible and could prove useful for in vivo assessment of CXCR4 expression.